dr. bellmunt on immunotherapy combination trials in bladder cancer
Published 6 years ago • 73 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
2:06
dr. bellmunt highlights immunotherapy options in bladder cancer
-
1:13
dr. bellmunt on challenges with immunotherapy in bladder cancer
-
2:58
dr. bellmunt discusses follow-up data for pembrolizumab vs chemotherapy in bladder cancer
-
1:30
dr. bellmunt on pd-l1 data in bladder cancer
-
1:19
dr. bellmunt shares keynote-045 data for pembrolizumab versus chemotherapy in bladder cancer
-
1:34
dr. bellmunt on immunotherapy plus ido in urothelial carcinoma
-
1:04
dr. plimack on immunotherapy combinations in bladder cancer
-
1:03:13
2024 cancer as a mitochondrial metabolic disease with professor thomas seyfried
-
8:38
#pembrolizumab | uses, dosage, side effects and mechanism | keytruda
-
42:23
bladder cancer | dr. tony talebi discusses "the treatment of stage 1 to 3 bladder cancer?"
-
4:44
changing trends in bladder cancer: bcg, precision medicine, and emerging therapies
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
1:08
dr. inman on immunotherapy combinations in bladder cancer
-
0:46
dr. hoffman-censits discusses immunotherapy in bladder cancer
-
1:00
dr. black on combinations with durvalumab in bladder cancer
-
19:21
immunotherapy for muscle invasive bladder cancer
-
1:34
dr. garcia on fda approval of pembrolizumab in bladder cancer
-
1:46
dr. iyer on advice for physicians using immunotherapy in bladder cancer
-
32:30
bladder cancer and immunotherapy with dr. terence friedlander
-
1:17
dr. grivas on promising combination therapies in bladder cancer
-
1:26
dr. sklar on challenges with clinical trials in bladder cancer
-
0:56
dr. apolo on immunotherapy combinations with cabozantinib in genitourinary tumors